HIV Gag polyprotein: Processing and early viral particle assembly

Trends in Microbiology

Volumn 21, Issue 3, 2013, Pages 136-144

  Bell, Neil M ^a   Lever, Andrew M L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Gag; HIV 1; RNA packaging; Viral assembly; Viral maturation

Indexed keywords

CA PROTEIN; GAG PROTEIN; GENOMIC RNA; MA PROTEIN; MESSENGER RNA; NC PROTEIN; PROTEIN P1; PROTEIN P2; PROTEIN P6; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; CELL MEMBRANE; GROUP SPECIFIC ANTIGEN GENE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR RECOGNITION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RETROVIRUS; REVIEW; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; VIROGENESIS; VIRUS ASSEMBLY; VIRUS CORE; VIRUS PARTICLE; VIRUS RELEASE; VIRUS VIRULENCE;

GENE PRODUCTS, GAG; HIV-1; PROTEIN BINDING; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84875233720     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2012.11.006     Document Type: Review

References (100)

1. Tazi J., et al. Alternative splicing: regulation of HIV-1 multiplication as a target for therapeutic action. FEBS J. 2010, 277:867-876.
2. Cullen B.R. Viral RNAs: lessons from the enemy. Cell 2009, 136:592-597.
3. de Breyne S., et al. Translation initiation is driven by different mechanisms on the HIV-1 and HIV-2 genomic RNAs. Virus Res. 2012, 10.1016/j.virusres.2012.10.006.
4. Balvay L., et al. Structural and functional diversity of viral IRESes. Biochim. Biophys. Acta 2009, 1789:542-557.
5. Anderson E.C., Lever A.M. Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation. J. Virol. 2006, 80:10478-10486.
6. Ratner L., et al. Complete nucleotide-sequence of the AIDS virus, HTLV-III. Nature 1985, 313:277-284.
7. Lever A.M. HIV-1 RNA packaging. Adv. Pharmacol. 2007, 55:1-32.
8. Carlton J.G., Martin-Serrano J. The ESCRT machinery: new functions in viral and cellular biology. Biochem. Soc. Trans. 2009, 37:195-199.
9. Hurley J.H. The ESCRT complexes. Crit. Rev. Biochem. Mol. Biol. 2010, 45:463-487.
10. Hurley J.H., Hanson P.I. Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat. Rev. Mol. Cell Biol. 2010, 11:556-566.
11. Carter C.A., Ehrlich L.S. Cell biology of HIV-1 infection of macrophages. Annu. Rev. Microbiol. 2008, 62:425-443.
12. Dordor A., et al. Essential and supporting host cell factors for HIV-1 budding. Future Microbiol. 2011, 6:1159-1170.
13. Martin-Serrano J., Neil S.J. Host factors involved in retroviral budding and release. Nat. Rev. Microbiol. 2011, 9:519-531.
14. Santos S., et al. Virus-producing cells determine the host protein profiles of HIV-1 virion cores. Retrovirology 2012, 9:65.
15. L'Hernault A., et al. Dimerisation of HIV-2 genomic RNA is linked to efficient RNA packaging, normal particle maturation and viral infectivity. Retrovirology 2007, 4:90.
16. de Marco A., et al. Structural analysis of HIV-1 maturation using cryo-electron tomography. PLoS Pathog. 2010, 6:e1001215.
17. Sakuragi J. Morphogenesis of the infectious HIV-1 virion. Front. Microbiol. 2011, 2:242.
18. L'Hernault A., et al. HIV-2 genome dimerization is required for the correct processing of Gag: a second-site reversion in matrix can restore both processes in dimerization-impaired mutant viruses. J. Virol. 2012, 86:5867-5876.
19. Ganser-Pornillos B.K., et al. The structural biology of HIV assembly. Curr. Opin. Struct. Biol. 2008, 18:203-217.
20. Briggs J.A.G., et al. Structure and assembly of immature HIV. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:11090-11095.
21. Briggs J.A., Krausslich H.G. The molecular architecture of HIV. J. Mol. Biol. 2011, 410:491-500.
22. Engelman A., Cherepanov P. The structural biology of HIV-1: mechanistic and therapeutic insights. Nat. Rev. Microbiol. 2012, 10:279-290.
23. Xue B., et al. Protein intrinsic disorder as a flexible armor and a weapon of HIV-1. Cell. Mol. Life Sci. 2012, 69:1211-1259.
24. Massiah M.A., et al. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J. Mol. Biol. 1994, 244:198-223.
25. Chukkapalli V., Ono A. Molecular determinants that regulate plasma membrane association of HIV-1 Gag. J. Mol. Biol. 2011, 410:512-524.
26. Hogue I.B., et al. Dynamic association between HIV-1 Gag and membrane domains. Mol. Biol. Int. 2012, 2012:979765.
27. Tang C., et al. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:517-522.
28. Saad J.S., et al. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11364-11369.
29. Fledderman E.L., et al. Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH. Biochemistry 2010, 49:9551-9562.
30. Alfadhli A., et al. Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids. J. Virol. 2009, 83:12196-12203.
31. Jones C.P., et al. Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding. J. Virol. 2011, 85:1594-1603.
32. Ghanam R.H., et al. Role of the HIV-1 matrix protein in Gag intracellular trafficking and targeting to the plasma membrane for virus assembly. Front. Microbiol. 2012, 3:55.
33. Kerviel A., et al. Virus assembly and plasma membrane domains: Which came first?. Virus Res. 2012, 10.1016/j.virusres.2012.08.014.
34. Alfadhli A., et al. Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer. J. Virol. 2007, 81:1472-1478.
35. Alfadhli A., et al. HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate. Virology 2009, 387:466-472.
36. Checkley M.A., et al. HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J. Mol. Biol. 2011, 410:582-608.
37. Datta S.A.K., et al. Conformation of the HIV-1 Gag protein in solution. J. Mol. Biol. 2007, 365:812-824.
38. Hurley J.H., et al. Membrane budding. Cell 2010, 143:875-887.
39. Worthylake D.K., et al. Structures of the HIV-1 capsid protein dimerization domain at 2.6 angstrom resolution. Acta Crystallogr. D: Biol. Crystallogr. 1999, 55:85-92.
40. Tang C., et al. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein. Nat. Struct. Biol. 2002, 9:537-543.
41. Jiang J.Y., et al. The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability. Virology 2011, 421:253-265.
42. Kelly B.N., et al. Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1-278) and CA(N)(133-278). Biochemistry 2006, 45:11257-11266.
43. Pornillos O., et al. X-ray structures of the hexameric building block of the HIV capsid. Cell 2009, 137:1282-1292.
44. Pornillos O., et al. Atomic-level modelling of the HIV capsid. Nature 2011, 469:424-427.
45. Mateu M.G. The capsid protein of human immunodeficiency virus: intersubunit interactions during virus assembly. FEBS J. 2009, 276:6098-6109.
46. Lopez C.S., et al. Determinants of the HIV-1 core assembly pathway. Virology 2011, 417:137-146.
47. Bharat T.A.M., et al. Structure of the immature retroviral capsid at 8 angstrom resolution by cryo-electron microscopy. Nature 2012, 487:385-389.
48. Mateu M.G. Assembly, stability and dynamics of virus capsids. Arch. Biochem. Biophys. 2012, 10.1016/j.abb.2012.10.015.
49. Meng X., et al. Protease cleavage leads to formation of mature trimer interface in HIV-1 capsid. PLoS Pathog. 2012, 8:e1002886.
50. von Schwedler U.K., et al. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 2003, 77:5439-5450.
51. Briggs J.A.G., et al. Structural organization of authentic, mature HIV-1 virions and cores. EMBO J. 2003, 22:1707-1715.
52. Lokhandwala P.M., et al. Cooperative role of the MHR and the CA dimerization helix in the maturation of the functional retrovirus capsid. Virology 2008, 376:191-198.
53. Purdy J.G., et al. Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly. J. Virol. 2008, 82:5951-5961.
54. Domenech R., et al. The isolated major homology region of the HIV capsid protein is mainly unfolded in solution and binds to the intact protein. Biochim. Biophys. Acta 2011, 1814:1269-1278.
55. Howard B.R., et al. Structural insights into the catalytic mechanism of cyclophilin A. Nat. Struct. Biol. 2003, 10:475-481.
56. Bosco D.A., et al. Dissecting the microscopic steps of the cyclophilin A enzymatic cycle on the biological HIV-1 capsid substrate by NMR. J. Mol. Biol. 2010, 403:723-738.
57. Luban J. TRIM5 and the regulation of HIV-1 infectivity. Mol. Biol. Int. 2012, 2012:426840.
58. Zhou D., et al. Cyclophilin A and viral infections. Biochem. Biophys. Res. Commun. 2012, 424:647-650.
59. Solbak S.M., et al. HIV-1 p6-Another viral interaction partner to the host cellular protein cyclophilin A. Biochim. Biophys. Acta 2012, 1824:667-678.
60. Waheed A.A., Freed E.O. HIV type 1 Gag as a target for antiviral therapy. AIDS Res. Hum. Retroviruses 2012, 28:54-75.
61. Neira J.L. The capsid protein of human immunodeficiency virus: molecular recognition and design of antiviral agents. FEBS J. 2009, 276:6097.
62. Bocanegra R., et al. Molecular recognition in the human immunodeficiency virus capsid and antiviral design. Virus Res. 2012, 169:388-410.
63. Newman J.L., et al. Flexibility in the P2 domain of the HIV-1 Gag polyprotein. Protein Sci. 2004, 13:2101-2107.
64. Morellet N., et al. Helical structure determined by NMR of the HIV-1 (345-392) Gag sequence, surrounding p2: Implications for particle assembly and RNA packaging. Protein Sci. 2005, 14:375-386.
65. Datta S.A.K., et al. On the role of the SP1 domain in HIV-1 particle assembly: a molecular switch?. J. Virol. 2011, 85:4111-4121.
66. Wright E.R., et al. Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J. 2007, 26:2218-2226.
67. Gross I., et al. A conformational switch controlling HIV-1 morphogenesis. EMBO J. 2000, 19:103-113.
68. Adamson C.S., et al. Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV-1 maturation inhibitor bevirimat. Retrovirology 2010, 7:36.
69. Godet J., et al. Comparative nucleic acid chaperone properties of the nucleocapsid protein NCp7 and Tat protein of HIV-1. Virus Res. 2012, 169:349-360.
70. Thomas J.A., Gorelick R.J. Nucleocapsid protein function in early infection processes. Virus Res. 2008, 134:39-63.
71. Crist R.M., et al. Assembly properties of human immunodeficiency virus type 1 Gag-leucine zipper chimeras: implications for retrovirus assembly. J. Virol. 2009, 83:2216-2225.
72. Hogue I.B., et al. Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding. J. Virol. 2009, 83:7322-7336.
73. Muriaux D., Darlix J.L. Properties and functions of the nucleocapsid protein in virus assembly. RNA Biol. 2010, 7:744-753.
74. Lu K., et al. Structural determinants and mechanism of HIV-1 genome packaging. J. Mol. Biol. 2011, 410:609-633.
75. Llewellyn G.N., et al. Nucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cells. PLoS Pathog. 2010, 6:e1001167.
76. Sandefur S., et al. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). J. Virol. 2000, 74:7238-7249.
77. Dussupt V., et al. The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding. PLoS Pathog. 2009, 5:e1000339.
78. Sette P., et al. Identification of the HIV-1 NC binding interface in ALIX Bro1 reveals a role for RNA. J. Virol. 2012, 86:11608-11615.
79. Popov S., et al. Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid. J. Virol. 2008, 82:1389-1398.
80. Darlix J.L., et al. Flexible nature and specific functions of the HIV-1 nucleocapsid protein. J. Mol. Biol. 2011, 410:565-581.
81. Saadatmand J., Kleiman L. Aspects of HIV-1 assembly that promote primer tRNA(Lys3) annealing to viral RNA. Virus Res. 2012, 169:340-348.
82. Williams M.C., et al. Specific zinc-finger architecture required for HIV-1 nucleocapsid protein's nucleic acid chaperone function. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:8614-8619.
83. Mirambeau G., et al. Transmission electron microscopy reveals an optimal HIV-1 nucleocapsid aggregation with single-stranded nucleic acids and the mature HIV-1 nucleocapsid protein. J. Mol. Biol. 2006, 364:496-511.
84. Cruceanu M., et al. Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins. Nucleic Acids Res. 2006, 34:593-605.
85. Wu T.Y., et al. Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications. Virology 2010, 405:556-567.
86. Narayanan N., et al. Structure/function mapping of amino acids in the N-terminal zinc finger of the human immunodeficiency virus type 1 nucleocapsid protein: residues responsible for nucleic acid helix destabilizing activity. Biochemistry 2006, 45:12617-12628.
87. Bell N.M., et al. Comparative structural effects of HIV-1 Gag and nucleocapsid proteins in binding to and unwinding of the viral RNA packaging signal. Biochemistry 2012, 51:3162-3169.
88. Hill M.K., et al. Alteration of the proline at position 7 of the HIV-1 spacer peptide p1 suppresses viral infectivity in a strain dependent manner. Curr. HIV Res. 2007, 5:69-78.
89. Hill M.K., et al. Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability. J. Virol. 2002, 76:11245-11253.
90. Coren L.V., et al. Mutational analysis of the C-terminal Gag cleavage sites in human immunodeficiency virus type 1. J. Virol. 2007, 81:10047-10054.
91. Morita E., Sundquist W.I. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 2004, 20:395-425.
92. Raiborg C., Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 2009, 458:445-452.
93. Morellet N., et al. Structure-function relationship of Vpr: biological implications. Curr. HIV Res. 2009, 7:184-210.
94. Kogan M., Rappaport J. HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention. Retrovirology 2011, 8:25.
95. 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virion. Retrovirology 2004, 1:26.
96. De Guzman R.N., et al. Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science 1998, 279:384-388.
97. Fossen T., et al. Solution structure of the human immunodeficiency virus type 1 p6 protein. J. Biol. Chem. 2005, 280:42515-42527.
98. Hill C.P., et al. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:3099-3104.
99. Zhai Q., et al. Structural and functional studies of ALIX interactions with YPXnL late domains of HIV-1 and EIAV. Nat. Struct. Mol. Biol. 2008, 15:43-49.
100. Pornillos O., et al. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat. Struct. Biol. 2002, 9:812-817.